Comparing the Effectiveness of Octenidine Hydrochloride and Chlorhexidine Gluconate Mouthrinses in Reducing Plaque and Oxidative Stress in Institutionalized Children with Down Syndrome
Anju S Raj, Sageena George, S Anandaraj, Jyoti Sumi Issac, Teena Haneef, Arjun Sreenivas
Citation Information :
Raj AS, George S, Anandaraj S, Issac JS, Haneef T, Sreenivas A. Comparing the Effectiveness of Octenidine Hydrochloride and Chlorhexidine Gluconate Mouthrinses in Reducing Plaque and Oxidative Stress in Institutionalized Children with Down Syndrome. Int J Clin Pediatr Dent 2024; 17 (4):437-441.
Background and objectives: Due to decreased manual dexterity, a lack of motivation, and difficulty on the part of the caregiver conducting efficient oral hygiene measures at home, patients with Down syndrome (DS) are badly affected. The objective of this study is to compare the efficacy of 0.1% octenidine (OCT) hydrochloride and 0.12% chlorhexidine (CHX) gluconate on plaque control and oxidative stress in institutionalized children with DS.
Materials and methods: In 20 children, salivary samples were collected for analysis of the inflammatory marker high-sensitive C-reactive protein (hsCRP) and oxidative stress markers, specifically malondialdehyde (MDA). Plaque index (PlI) and gingival index (GI) were scored. After oral prophylaxis, the participants were randomly assigned to two groups, each consisting of 10 individuals (octenidol and CHX). Salivary oxidative stress marker assays were carried out using a modified version of Yagi's (1984) method, and absorbance was measured at 540 nm using an ultraviolet-visible spectrophotometer at 535 nm. hsCRP assays were conducted via latex turbidimetric immunoassay.
Results: On comparison between the two groups, the OCT group showed a statistically significant reduction in GI, PlI, and MDA values (p < 0.05).
Conclusion: It was seen that the use of 0.1% OCT hydrochloride could facilitate the maintenance of good oral hygiene and periodontal status, especially in patients with motor difficulties.
Clinical trial registration: PMS/IEC/2016/02.
Nelson LP, Getzin A, Graham D, et al. Unmet dental needs and barrier to care for children with significant special health care needs. Pediatr Dent 2011;33(1):29–36.
de Sousa M, Vieira RB, Dos Santos DS, et al. Antioxidants and biomarkers of oxidative damage in the saliva of patients with Down's syndrome. Arch Oral Biol. 2015;60(4):600–605. DOI: 10.1016/j.archoralbio.2014.09.013
Khocht A, Janal M, Turner B. Periodontal health in Down syndrome: contributions of mental disability, personal, and professional dental care. Spec Care Dent 2010;30(3):118–123. DOI: 10.1111/j.1754-4505.2010.00134.x
Desai SS. Down syndrome: a review of the literature. Oral Surg Oral Med Oral Med Oral Pathol Oral Radiol Endod 1997;84(3):279–285. DOI: 10.1016/s1079-2104(97)90343-7
Mann J, Wolnerman JS, Lavie G, et al. Periodontal treatment need sand oral hygiene for institutionalized individuals with handicapping conditions. Spec Care Dent 1984;4(4):173–176. DOI: 10.1111/j.1754-4505.1984.tb00358.x
Slee AM, O'Connor JR. In vitro antiplaque activity of octenidine dihydrochloride (WIN 41464-2) against preformed plaques of selected oral plaque-forming microorganisms. Antimicrob Agents Chemother 1983;23(3):379–384. DOI: 10.1128/AAC.23.3.379
American Academy of Pediatric Dentistry. Symposium on lifetime oral health care for patients with special needs. Pediatr Dent 2007;92–152.
Thikkurissy S, Lal S. Oral health burden in children with systemic diseases. Dent Clin North Am 2009;53(2):351–357. DOI: 10.1016/j.cden.2008.12.004
Stabholz A, Shapira J, Shur D, et al. Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population. Clin Prev Dent 1991;13(5):9–14.
Teitelbaum AP, Pochapski MT, Jansen JL, et al. Evaluation of the mechanical and chemical control of dental biofilm in patients with Down syndrome. Community Dent Oral Epidemiol 2009;37(5):463–467. DOI: 10.1111/j.1600-0528.2009.00488.x
Stingeni L, Lapomarda V, Lisi P. Occupational hand dermatitis in hospital environments. Contact Dermatitis 1995;33(3):172–176. DOI: 10.1111/j.1600-0536.1995.tb00540.x
Rohrer N, Widmer AF, Waltimo T, et al. Antimicrobial efficacy of 3 oral antiseptics containing octenidine. Infect Control Hosp Epidemiol 2010;31(7):733–739. DOI: 10.1086/653822
Patters MR, Anerud K, Trummel CL, et al. Inhibition of plaque formation in humans by octenidine mouthrinse. J Periodontal Res 1983;18(2):212–219. DOI: 10.1111/j.1600-0765.1983.tb00354.x
Beiswanger BB, Mallatt ME, Mau MS, et al. The clinical effects of a mouthrinse containing 0.1% octenidine. J Dent Res 1990;69(2):454–457. DOI: 10.1177/00220345900690020701
